Article: Paget's patients develop resistance to pamidronate.(Metabolic Disorders)

FORT LAUDERDALE, FLA. -- Reduced responsiveness to repeat bisphosphonate treatment in patients with Paget's disease of bone appears to be limited to pamidronate and may not be a problem with the newer, more potent agents, Dr. Socrates Papapoulos said at a meeting sponsored by the Paget Foundation for Paget's Disease of Bone and Related Disorders.

"The issue of bisphosphonate resistance does not appear to be of primary importance for our clinical practice, especially with the more potent agents now available," said Dr. Papapoulos, professor of medicine and director of bone and mineral research at Leiden (the Netherlands) University Medical Center.

For ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!